Cataract progression after Nd-YAG laser iridotomy in primary angle-closure suspect eyes
2 February 2024
| Jonathan Chan
|
EYE - Glaucoma
|
Angle, Clinical Trial, Glaucoma, Treatment Lasers, Vision
A total of 889 of eligible bilateral primary angle-closure suspect (PACS) patients were recruited from the Zhongshan Angle Closure Prevention Trial. One randomly selected eye received laser peripheral iridotomy (LPI), while the fellow remained untreated. Cataract was graded by the...
Optic disc haemorrhages as a risk factor for poor outcomes in IIH
This is a report of a review of optic disc photographs, of the type and frequency of the optic disc haemorrhages (ODH), papilloedema grades and other fundoscopic abnormalities at baseline. In the study eyes of 133 patients enrolled in the...
Intracameral bevacizumab as an adjunct to trabeculectomy
This is a 12-month, prospective, randomised, double-masked, placebo-controlled trial of patients who were not controlled medically with open angle glaucoma and scheduled for a primary trabeculectomy. Patients were recruited and randomised during the period between April 2009 and November 2010....
